Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey
  4. Texas Health Center COVID-19 Survey Summary Report

Texas Health Center COVID-19 Survey Summary Report

Latest data from May 6, 2022

Number of Health Center respondents = 60 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 5,477
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 85.34%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 210
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 77.78%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 13.13% 20.00%
White, Hispanic/Latino Patients 60.25% 56.19%
Black/African American, Non-Hispanic/Latino Patients 6.45% 7.62%
Black/African American, Hispanic/Latino Patients 0.62% 0.00%
Asian Patients3 1.21% 0.95%
American Indian/Alaska Native Patients3 0.38% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.26% 0.48%
Patients with More Than One Race3 2.10% 0.95%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.19% 3.81%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.39% 0.48%
Unreported/Refused to Report Race and Ethnicity 9.04% 9.52%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 661
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 90.43%
COVID-19 Immunization Series Completed 661
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 91.97%
COVID-19 Immunization Series Additional 1,613
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 87.52%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 9.08% 7.41% 12.09%
White, Hispanic/Latino Patients 67.17% 64.75% 64.41%
Black/African American, Non-Hispanic/Latino Patients 7.72% 7.72% 7.07%
Black/African American, Hispanic/Latino Patients 1.51% 0.76% 0.56%
Asian Patients3 1.36% 1.66% 1.49%
American Indian/Alaska Native Patients3 0.45% 0.15% 2.67%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.15% 0.19%
Patients with More Than One Race3 1.51% 0.91% 0.37%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.05% 8.77% 8.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.82% 1.21% 0.74%
Unreported/Refused to Report Race and Ethnicity 3.33% 6.51% 2.42%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 35.00%
1 to 24 Hours 35.00%
More Than 24 Hours 28.33%
N/A 1.67%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 10.00%
Staffing to administer the vaccine 18.33%
Vaccine confidence 25.00%
Vaccine storage capacity 5.00%
Vaccine supply 1.67%
Other 11.67%
None 45.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 33.33%
Average Percent of Health Center Visits Conducted Virtually 12.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 26.67%
Number of Mobile Van Sites 7
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 5
Number of Family Vaccination Clinics 36

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 1.67%
Refer patients to another organization that provides monoclonal antibody therapies 60.00%
None 38.33%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 13.33%
Patient awareness/education 3.33%
Staffing capacity 21.67%
Therapy administration/onsite logistics 18.33%
Other 5.00%
None 61.67%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 33
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 54,682

Test Kit Distribution Methods4

Metrics Value
Provided to Existing Health Center Patients 75.76%
Provided to General Public Who Came to the Health Center 51.52%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 24.24%
Provided at Other Community Events 27.27%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 9.09%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 24.24%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 15.15%
Provided to school-age children and/or their families directly or through partnerships with schools 18.18%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 18.18%
Other 3.03%

N95 Mask Distribution

Metrics Value
Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program 19
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 29,819

N95 Mask Distribution Methods5

Metrics Value
Provided to Existing Health Center Patients 89.47%
Provided to General Public Who Came to the Health Center 42.11%
Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 26.32%
Provided at Other Community Events 26.32%
Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals 15.79%
Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals 31.58%
Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals 31.58%
Provided to school-age children and/or their families directly or through partnerships with schools 21.05%
Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities 26.32%
Other 5.26%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 8
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication 95.12%

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 0.00%
White, Hispanic/Latino Patients 82.93%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 0.00%
American Indian/Alaska Native Patients3 2.44%
Native Hawaiian/Other Pacific Islander Patients3 2.44%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.32%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.00%
Unreported/Refused to Report Race and Ethnicity 4.88%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 0.00%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 4.88%
Patients with Limited English Proficiency 17.07%
Children Under 18 Years of Age 2.44%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.

Date Last Reviewed: